Addressing the Challenge of Drug Safety in Early Discovery

Posted by

SELECTBIO

Drug toxicity is one of the major causes of attrition in preclinical and clinical development. GSK has developed a number of high throughput techniques to assess the potential for safety liabilities in chemical series in early discovery.